Home > Press > Nanogate AG: BIP Investment Partners becomes new anchor investor
Abstract:
Luxembourg-based investment company acquires 10.5% of Nanogate shares - Long-term investment planned, minimum holding period 1 year
Saarbrucken, 25 July 2007. Nanogate AG (ISIN DE 000A0JKHC9) has
gained a long-term investor. The Luxembourg-based investment
company BIP Investment Partners is acquiring 10.5% of shares in the
company as a long-term commitment. The contractually agreed lock-up
period is one year.
BIP Investment Partners is acquiring off-market 200,000 shares of which the
majority is from the Nanogate Technologies GmbH holding, consisting mainly of
equity held by financial investors (3i, Sal. Oppenheim, equinet ESCFI, SET). To
make up the 10.5%, NanoTec Beteiligungen GmbH (Management) is also
contributing shares. Secrecy was agreed on the purchase price. BIP Investment
Partners is an independent equity investment company listed in Luxembourg. It
currently manages a volume of €600 million and holds shares in more than 30
companies, including indirectly two nanotechnology firms. The largest
shareholder in BIP Investment Partners, which was founded in April 2000, is
Fortis Banque Luxembourg.
Marc Faber, General Manager of BIP Investment Partners, said, "Nanogate AG
has a very interesting business model and very good management. It is
outstandingly well positioned strategically and extremely successful
operationally. We aim to accompany Nanogate on a long-term basis as a
generator of ideas. We are convinced that our commitment will pay off in many
ways." Within the scope of its equity holding the new anchor investor will make
use of its existing network to support the company on its growth course. "BIP
Investment Partners' commitment to Nanogate confirms us in our conviction that
our business has enormous growth potential. We are delighted to have gained
the extra expertise and good contacts," said Ralf Zastrau, CEO of Nanogate AG.
"We anticipate additional positive effects in the implementation of our NEXT
growth programme." Saarbrücken-based Nanogate AG is currently growing
dynamically and recently gained access to the US market with a large order
placed by a leading bathroom fixtures company. For the past three years, sales
have grown by an average of 65.7% per annum.
As a result of the transaction Nanogate AG's shareholder structure will in future
be as follows:
Free float: 31.7%
Nanogate Technologies GmbH: 49.6%
BIP Investment Partners: 10.5%
NanoTec Beteiligungen GmbH: 8.2%
####
About Nanogate AG
The Nanogate AG is an internationally leading enabler in the growth market of nanotechnology. We enhance our customers´ and partners´ products, hence providing them with extra added value and a competitive edge. We open the gateway to nanotechnology for the most varied of industrial sectors.
Taking Nanogate Technologie® as a basis, we create new functions by programming materials. From the development and production of innovative nano composites and nano formulations through to comprehensive product and process integration, we offer competence as a partner in innovation and implementation. Take advantage of our added value potential!
For more information, please click here
Contacts:
Christian Dose (Financial information)
equinet Communications AG
Tel.: +49/(0)69/58 997 313
Christian Daumann (Trade press)
MPW Finance Public & Investor Relations GmbH
Telefon: +49/(0)69/95 92 90-0
Nanogate AG
Gewerbepark Eschbergerweg
D-66121 Saarbrücken
http://www.nanogate.com
Copyright © Nanogate AG
If you have a comment, please Contact us.Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Related News Press |
Investments/IPO's/Splits
Daikin Industries becomes OCSiAl shareholder July 27th, 2021
INBRAIN Neuroelectronics raises over €14M to develop smart graphene-based neural implants for personalised therapies in brain disorders March 26th, 2021
180 Degree Capital Corp. Issues Second Open Letter to the Board and Shareholders of Enzo Biochem, Inc. March 26th, 2021
Announcements
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||